Fundraising Fox
Advanced BioDesign
1 known investors
Find your way into Advanced BioDesign
Sign up to see every warm intro you have to Advanced BioDesign
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Advanced BioDesign team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Advanced BioDesign is a clinical-stage French biotechnology company developing small-molecule ALDH1 enzyme inhibitors to overcome drug resistance in chemotherapy-resistant cancers. Its work targets oncology indications such as acute myeloid leukemia, non-small cell lung cancer, and melanoma, alongside a companion diagnostic to stratify patients.
Investors · 1
In the news
Frequently asked questions
- What does Advanced BioDesign do?
- Advanced BioDesign is a clinical-stage French biotechnology company developing small-molecule ALDH1 enzyme inhibitors to overcome drug resistance in chemotherapy-resistant cancers. Its work targets oncology indications such as acute myeloid leukemia, non-small cell lung cancer, and melanoma, alongside a companion diagnostic to stratify patients.
- Who are Advanced BioDesign's investors?
- Advanced BioDesign's investors include Xerys.